Literature DB >> 3905577

Shock-related injury of pancreatic islets of Langerhans in newborn and young infants.

T A Seemayer, C Osborne, J P de Chadarévian.   

Abstract

Variable degrees of injury of the pancreatic islets of Langerhans, with sparing of the acinar pancreas, were observed in three infants (age range, 1 day to 3 months) who died of profound shock. The duration of shock varied from 19 to 48 hours. In two of the infants, the shock stemmed from hypovolemia; in the remaining infant, the shock followed blood loss, sepsis, and heart failure. The islet lesions were devoid of cellular infiltrates, hemorrhage, and fibrin thrombi. Tissue manifestations of shock included acute renal tubular necrosis, massive hepatic centrilobular necrosis, ischemic enteropathy, and "shock" lung. Study of pancreatic sections from 30 children (age range, 13 hours to 15 years) with clinical and/or morphologic evidence of shock showed no additional instances of islet injury. These findings suggest that pancreatic islets in the young may be vulnerable to shock-induced ischemia. Studies are in progress in an animal model to test this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905577     DOI: 10.1016/s0046-8177(85)80035-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Islet cell necrosis in the neonatal pancreas: a report of three cases.

Authors:  P F Roberts
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

2.  Pancreatic ischaemic lesions without fat necrosis associated with disseminated intravascular coagulation.

Authors:  S Matsukuma; K Suda; S Ishihara; M Tsukahara
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

3.  Obliterative segmental sclerosis of pancreatic islets. A possible consequence of hypotensive shock in young BB rats.

Authors:  T A Seemayer; J F Yale; J P de Chadarévian; M Grose; E B Marliss
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.